期刊文献+

酮替芬对高糖高脂饮食诱导肥胖模型大鼠的减肥作用 被引量:2

Antiobesity effect of ketotifen in high-carbon hydrate-fat diet induced obese rats
暂未订购
导出
摘要 目的:探讨酮替芬对高糖高脂饮食诱导的大鼠肥胖模型的减肥作用及其机制。方法:SD大鼠随机分成肥胖模型组、酮替芬干预组和正常对照组,肥胖模型组和酮替芬干预组以高糖高脂饲料饲喂,正常对照组以基础饲料饲喂,酮替芬干预组每天灌胃给予酮替芬0.09mg/kg,持续12周。称重,计算Lee's指数,检测空腹血糖(FBG)、空腹胰岛素(FINS)、瘦素(LEP)、游离脂肪酸(FFA)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α);检测白色脂肪解偶联蛋白2(UCP2)mRNA的表达。结果:酮替芬明显降低肥胖模型大鼠的体质量及Lee's指数(P<0.05),降低FBG、FINS和LEP水平(P<0.05),降低FFA、TG和LDL-C水平(P<0.05)和IL-6、TNF-α水平(P<0.05),而增加UCP2mRNA的表达水平(P<0.05)。结论:酮替芬能够降低肥胖模型大鼠炎症介质和游离脂肪酸水平,减轻高胰岛素血症和高瘦素血症,促进脂肪组织能量代谢,实现减肥作用。 AIM. To investigate the antiobe- sity effect and mechanism of ketotifen in high- carbon hydrate-fat diet induced obese rats. METHODS. Male SD rats were randomly divided into three groups, obese group, ketotifen group and normal control group. Rats of obese group and ketotifen group were fed with high-carbon hydrate-fat diet, while the rats of normal control group were fed with basal feed. Rats of ketotifen group were daily given a gavage of ketotifen 0.09 mg/kg for 12 weeks. The body weights were tested and then the Lee's indexes were cal- culated,The fasting blood glucose(FBG),fasting insulin(FINS) and leptin(LEP), free fatty acid (FFA), riglyceride(TG) and low density lipo- protein cholesterin (LDL-C), interleukin -6 (IL- 6) and tumor nectosis factor-alpha(TNF-α) were analyzed, UCP2 mRNA in white adipose weremeasured. RESULTS: Ketotifen reduced body weight and Lee's indexes obviously in obese rats (P〈0.05), lowered FBG,FINS and LEP levels and reduced FFA, TG and LDL-C levels signifi- cantly(P〈0.05). Furthermore, ketotifen could decrease IL-6 and TNF-α levels and increase the UCP2 mRNA expression obviously(P〈0.05). CONCLUSION: Ketotifen has antiobesity effects on high-carbon hydrate-fat diet induced obese rats by reduction of inflammation medium and free fatty acid leves,alleviation of hyperinsuline- mia and hyperleptindemia and promotion of adi- pose tissue energy metabolism.
出处 《中国临床药理学与治疗学》 CAS CSCD 2014年第1期23-28,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 浙江省自然科学基金(LQ12H07003) 温州市科技局基金资助(Y20100063)
关键词 酮替芬 肥胖 肥大细胞 炎症 解偶联 蛋白2 Ketotifen Obesity Mast cellInflammation UCP2
  • 相关文献

参考文献3

二级参考文献20

  • 1Rimbach G, Boesch-Saadatmandi C, Frank J. Dietary isoflavones in the prevention of cardiovascular disease-A molecular perspective[ J]. Food Chem Toxicol, 2008,46 (4) : 1308 - 1319.
  • 2Marla SJ, Manzoni MSc, Elizeu A, et al. Fermented soy product supplemented with isoflavones affected fat depots in juvenile rats[J]. Nutrition, 2005, 21 (10) : 1018 - 1024.
  • 3Naaz A, Yellayi S, Zakroczymski MA, et al. The soy isoflavone genistein decreases adipose deposition in mice[J]. Endocrinology, 2003,144(8) :3315 - 3320.
  • 4Yang JY, Della-Fera MA, Baile CA, Guggulsterone inhibits adipocyte differentiation and induces apoptosis in 3TS-L1 Cells[J]. Obesity, 2008,16(1) : 16 - 22.
  • 5Moreno DA, Ilic N, Poulev A. Effects of Arachis hypogaeanutshell extract on lipid metabolic enzymes and obesity parameters[J]. Life Sci, 2006,78(24) : 2797 - 2803.
  • 6Alan J, Lee H, Kim S, et al. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways[ J]. Biochem Biophys Res Commun, 2008,373 (4) :545 - 549.
  • 7Moon HS, Lee HG, Choi YJ, et al. Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity [J]. Chem Biol Interact, 2007, 167(2) :85 - 98.
  • 8Haemmerle G, Zimmermann R, Zechner R. letting lipids go: hormone-sensitive lipase [J]. Curr Opin Lipidol, 2003,14(3) :289 - 297.
  • 9Langin D. Adipose tissue lipolysis as a metabolie pathway to define pharmacological strategies against obesity and the metabolic syndrome [ J ]. Pharmaeol Res, 2006, 53 ( 6 ) : 482 - 491.
  • 10Hodsona L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake[J]. Prog Lipid ties, 2008,47 (5) :348 - 380.

共引文献5

同被引文献27

  • 1Giovanni Tarantino,Carmine Finelli.What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?[J].World Journal of Gastroenterology,2013,19(22):3375-3384. 被引量:35
  • 2王炳芳,朱韶杰,田培营.脂肪肝细胞模型的建立及其生物学特性[J].世界华人消化杂志,2007,15(35):3674-3677. 被引量:12
  • 3Watanabe T, Yanai K. Studies on functional roles of the histaminergic neuron system by using pharmacolog- ical agents, knockout mice and positron emission tomography[ J ]. Tohoku J Exp Med, 2001,195 (4) : 197-217.
  • 4Masaki T, Chiba S, Yasuda T, et al. Involvemwnt of hypothalamid histamine H1 receptor in the regulation of feeding rhythm and obesity [ J ]. Diabetes, 2004,53 (9) :2250-2260 .
  • 5Lian J, Huang XF, Pai N, et al. Preventing olanzapine- induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment [ J ]. PLoS One ,201d ,9 (8) : e104160.
  • 6Wang KY, Tanimoto A, Yamada S, et al. Histamine regulation in glucose and lipid metabolism via hista- mine receptors [ J ]. Am J Pathol, 2010,177 ( 2 ) : 713- 723.
  • 7Sethi J, Sanchez-Alavez M,Tabarean IV. Loss of hista- minergic modulation of thermoregulation and energy homeostasis in obese mice [ J ]. Neuroscience, 2012, 217(16) : 84-95.
  • 8Wang KY, Tanimoto A, Yamada S, et al. Histamine Regulation in Glucose and Lipid Metabolism via Hista- mine Receptors [ J ]. The American Journal of Patholo- gy, 2010,177(2) :713-723.
  • 9Sakata T, Masaki H, Masaki T. Anti-obesity actions of mastication driven by histamine neurons in rats [ J ]. Exp Biol Med ( Maywood), 2003 , 228 (10) : 1106-1110.
  • 10Zhang J, Shi GP. Mast cells and metabolic syndrome [J]. Biochim Biophys Acta,2012 ,1822(1 ): 14-20.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部